Search results for " DIALYSIS"

showing 10 items of 177 documents

Single‐agent daratumumab in patients with relapsed and refractory multiple myeloma requiring dialysis: results of a Spanish retrospective, multicentr…

2019

Correspondence.

MaleOncologymedicine.medical_specialtymedicine.medical_treatmentDisease-Free SurvivalRecurrenceRenal DialysisMultiple myelomaDaratumumabInternal medicinemedicineHumansIn patientSingle agentRelapseDialysisMultiple myelomaAgedRetrospective Studiesrelapsebusiness.industryAntibodies MonoclonalDaratumumabRefractory Multiple MyelomaHematologyMiddle Ageddaratumumabmedicine.diseasemultiple myelomaSurvival RatedialysisFemalebusinessDialysisBritish Journal of Haematology
researchProduct

Neutral pH and low–glucose degradation product dialysis fluids induce major early alterations of the peritoneal membrane in children on peritoneal di…

2018

WOS: 000439138700024 PubMed ID: 29776755 The effect of peritoneal dialysates with low-glucose degradation products on peritoneal membrane morphology is largely unknown, with functional relevancy predominantly derived from experimental studies. To investigate this, we performed automated quantitative histomorphometry and molecular analyses on 256 standardized peritoneal and 172 omental specimens from 56 children with normal renal function, 90 children with end-stage kidney disease at time of catheter insertion, and 82 children undergoing peritoneal dialysis using dialysates with low-glucose degradation products. Follow-up biopsies were obtained from 24 children after a median peritoneal dial…

MalePathologymedicine.medical_specialtyEpithelial-Mesenchymal TransitionAdolescentmedicine.medical_treatmentBiopsy030232 urology & nephrologyMedizinPeritonitis030204 cardiovascular system & hematologyPeritonitisperitoneal membranePeritoneal dialysis03 medical and health sciences0302 clinical medicinePeritoneumFibrosisDialysis SolutionsmedicineLymphatic vesselHumansChildDialysisCatheter insertionChemistryInfantHydrogen-Ion Concentrationmedicine.diseaseFibrosismedicine.anatomical_structureGlucoseTreatment Outcomeperitoneal dialysisNephrologyCase-Control StudiesChild PreschoolKidney Failure ChronicFemalePeritoneumchronic kidney diseaseKidney disease
researchProduct

Performance of a Predictive Model for Long-Term Hemoglobin Response to Darbepoetin and Iron Administration in a Large Cohort of Hemodialysis Patients

2016

International audience; Anemia management, based on erythropoiesis stimulating agents (ESA) and iron supplementation, has become an increasingly challenging problem in hemodialysis patients. Maintaining hemodialysis patients within narrow hemoglobin targets, preventing cycling outside target, and reducing ESA dosing to prevent adverse outcomes requires considerable attention from caregivers. Anticipation of the long-term response (i.e. at 3 months) to the ESA/iron therapy would be of fundamental importance for planning a successful treatment strategy. To this end, we developed a predictive model designed to support decision-making regarding anemia management in hemodialysis (HD) patients tr…

MalePediatricsBlood transfusionDarbepoetin alfaPhysiologymedicine.medical_treatment030232 urology & nephrologylcsh:Medicine030204 cardiovascular system & hematologyFerric CompoundsBiochemistryGlucaric AcidHemoglobinsMathematical and Statistical Techniques0302 clinical medicineMedicine and Health SciencesDarbepoetin alfaErythropoiesislcsh:ScienceFerric Oxide SaccharatedMultidisciplinaryPharmaceuticsDisease ManagementAnemia[SDV.MHEP.HEM]Life Sciences [q-bio]/Human health and pathology/HematologyHematologyMiddle Aged3. Good healthNephrologyInjections IntravenousPhysical SciencesFemaleHemodialysisStatistics (Mathematics)Research Articlemedicine.drugComputer and Information Sciencesmedicine.medical_specialtyAnemiaResearch and Analysis Methods03 medical and health sciencesDose Prediction MethodsRenal DialysisArtificial IntelligenceMedical DialysismedicineHumansHemoglobinDosingStatistical MethodsIron Deficiency AnemiaIntensive care medicineArtificial Neural NetworksAgedRetrospective StudiesComputational NeuroscienceModels Statisticalbusiness.industrylcsh:RBiology and Life SciencesComputational BiologyProteinsRetrospective cohort studymedicine.diseaseIron-deficiency anemiaHematinicsKidney Failure ChronicCognitive Sciencelcsh:QNeural Networks ComputerHemoglobinPhysiological ProcessesbusinessMathematicsNeuroscienceForecasting
researchProduct

Nutritional Status of Maintenance Dialysis Patients: Low Lean Body Mass Index and Obesity Are Common, Protein-Energy Wasting Is Uncommon.

2016

Background and Aims Maintenance dialysis patients are at increased risk of abnormal nutritional status due to numerous causative factors, both nutritional and non-nutritional. The present study assessed the current prevalence of protein-energy wasting, low lean body mass index and obesity in maintenance dialysis patients, and compared different methods of nutritional assessment. Methods In a cross-sectional study conducted in 2014 at Roskilde Hospital, Denmark, we performed anthropometry (body weight, skinfolds, mid-arm, waist, and hip circumferences), and determined plasma albumin and normalized protein catabolic rate in order to assess the prevalence of protein-energy wasting, low lean bo…

MalePediatricsProtein–energy malnutritionPhysiologyCross-sectional study030232 urology & nephrologySocial Scienceslcsh:Medicine030204 cardiovascular system & hematologyBiochemistryBody Mass IndexFats0302 clinical medicinePrevalenceMedicine and Health SciencesYoung adultlcsh:ScienceWastingAged 80 and overMultidisciplinaryAnthropometryMiddle AgedLipidsPhysiological ParametersNephrologyPhysical SciencesBody CompositionEngineering and TechnologyFemalePhysical AnthropologyWaist Circumferencemedicine.symptomResearch ArticleAdultmedicine.medical_specialtyMaterials ScienceNutritional StatusFuelsProtein-Energy MalnutritionYoung Adult03 medical and health sciencesRenal DialysisAlbuminsInternal medicineMedical DialysismedicineHumansObesityMaterials by AttributeAgedNutritionbusiness.industryBody Weightlcsh:RBiology and Life SciencesProteinsAnthropometrymedicine.diseaseObesityEnergy and PowerCross-Sectional StudiesEndocrinologyAnthropologyLean body massKidney Failure Chroniclcsh:QbusinessBody mass indexPLoS ONE
researchProduct

Applicability and safety of discontinuous ADVanced Organ Support (ADVOS) in the treatment of patients with acute-on-chronic liver failure (ACLF) outs…

2021

Background ADVanced Organ Support (ADVOS) is a novel type of extracorporeal albumin dialysis and holds promise to sustain liver function and recovery of patients with acute-on-chronic liver failure (ACLF). Previously, ADVOS was tested as continuous treatment for intensive care patients with liver failure. Data related to the applicability and safety as discontinuous treatment outside of ICU is not available. Aim Evaluation of ADVOS as discontinuous treatment for patients with ACLF outside intensive care unit and comparison with a matched historic cohort. Methods and results In this retrospective study, 26 patients with ACLF and the indication for renal replacement therapy related to HRS-AK…

MalePhysiologymedicine.medical_treatmentLiver transplantationToxicologyPathology and Laboratory MedicineSeverity of Illness IndexBiochemistrylaw.inventionBlood Urea Nitrogen0302 clinical medicinelawLiver Cirrhosis AlcoholicMedicine and Health SciencesMedicineBileMultidisciplinaryLiver DiseasesQRMiddle AgedIntensive care unitBody FluidsRenal Replacement TherapyLiverCirrhosisNephrologyCreatinineMedicine030211 gastroenterology & hepatologyFemaleHemodialysisAnatomyDetoxificationResearch Articlemedicine.medical_specialtyCritical CareScienceSurgical and Invasive Medical ProceduresGastroenterology and Hepatology03 medical and health sciencesDigestive System ProceduresRenal DialysisIntensive careInternal medicineAlbuminsMedical DialysisHumansRenal replacement therapyDialysisRetrospective StudiesTransplantationbusiness.industryAcute-On-Chronic Liver FailureBiology and Life SciencesProteins030208 emergency & critical care medicineRetrospective cohort studyBilirubinOrgan TransplantationSurvival AnalysisLiver TransplantationPatient ComplianceLiver functionbusinessBiomarkersPLoS ONE
researchProduct

Late, giant brachial artery aneurysm following hemodialysis fistula ligation in a renal transplant patient: case report and literature review.

2012

Brachial artery aneurysm (BAA) following long-standing arteriovenous fistula ligation after renal transplantation is uncommon. Herein, we describe the case of a 64-year-old man who developed a giant symptomatic BAA 21 years after ligation of the fistula. He was submitted to surgical excision of the aneurysm followed by interposition prosthetic graft.

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyBrachial ArteryFistulamedicine.medical_treatmentArteriovenous fistulaSettore MED/22 - Chirurgia VascolareArteriovenous Shunt SurgicalAneurysmRenal Dialysismedicine.arterymedicineHumanscardiovascular diseasesBrachial arteryLigationbusiness.industryBrachial artery aneurysm Renal transplantation Dialysis Surgical bypassGeneral MedicineMiddle Agedmedicine.diseaseAneurysmKidney TransplantationSurgeryTransplantationCardiothoracic surgerycardiovascular systemSurgeryRadiologyHemodialysisCardiology and Cardiovascular MedicineLigationbusiness
researchProduct

Impact of Sarcopenia on Clinical Outcomes of Patients Undergoing Simultaneous Liver and Kidney Transplantation: A Cohort Study

2021

International audience; Background: The impact of sarcopenia in patients undergoing simultaneous liver and kidney transplantation (SLKT) has not been fully delineated. The aim of this single-centre-cohort-study was to evaluate the impact of sarcopenia on the clinical outcomes. Methods: Between 2003 and 2018, 79 patients underwent SLKT. Sarcopenia was assessed via the total psoas muscle area (TPA) at the level of the 3rd. lumbar vertebra. Sarcopenia threshold was TPA < 1460 mm2 (women) and <1560 mm2 (men). We identified post-operative biliary, vascular and digestive complications. Survival analysis was performed by the Kaplan Meier method (log-rank test). Results: We included 43/79 SLK…

MaleSarcopeniamedicine.medical_specialtymedicine.medical_treatment[SDV]Life Sciences [q-bio]Liver transplantationCohort Studies03 medical and health sciences0302 clinical medicineRenal DialysisInternal medicinemedicineHumansKidney transplantationDialysisHepatologybusiness.industryGastroenterologyPostoperative complicationMiddle Agedmedicine.diseaseKidney TransplantationLiver TransplantationTransplantationTreatment Outcome030220 oncology & carcinogenesisSarcopeniaCohortFemale030211 gastroenterology & hepatologybusinessCohort study
researchProduct

Determinants of enhanced thromboxane biosynthesis in renal transplantation

2001

Determinants of enhanced thromboxane biosynthesis in renal transplantation.BackgroundDespite great improvement in patient and graft survival, the long-term morbidity and mortality in renal transplant recipients (RTRs) are still significant, with a high incidence of cardiovascular disease-related deaths.MethodsWe investigated thromboxane (TXA2) biosynthesis and endothelial and coagulative activation in 65 patients who received a renal transplant.ResultsThe rate of TXA2 biosynthesis (urinary 11-dehydro-TXB2 excretion largely reflects platelet TXA2 production in vivo) was significantly (P < 0.0001) higher in RTRs than in healthy subjects. Plasma von Willebrand factor (vWF) and thrombin-antithr…

MaleSettore MED/09 - Medicina InternaThromboxanegraft survivalThromboxanevon Willebrand factorImmunosuppressive AgentThromboxane A2chemistry.chemical_compoundReference ValuesRenal Dialysicardiovascular diseaseReference ValuePlateletPostoperative PeriodKidney transplantationKidneyimmunosuppressionnephrotoxicityThromboxanesMiddle AgedCholesterolmedicine.anatomical_structureNephrologyCyclosporineFemaleCardiovascular disease; Graft survival; Immunosuppression; Kidney transplantation; Nephrotoxicity; Von Willebrand factor; Adult; Antithrombin III; Cardiovascular Diseases; Cholesterol; Cyclosporine; Female; Follow-Up Studies; Humans; Immunosuppressive Agents; Male; Middle Aged; Peptide Hydrolases; Postoperative Period; Reference Values; Renal Dialysis; Thromboxanes; von Willebrand Factor; Kidney Transplantation; NephrologyImmunosuppressive AgentsHumancirculatory and respiratory physiologyAdultmedicine.medical_specialtyAntithrombin IIIUrologykidney transplantationFollow-Up StudieEndothelial activationRenal DialysismedicineHumansPlatelet activationcardiovascular disease; cardiovascular diseases; graft survival; immunosuppression; kidney transplantation; nephrotoxicity; von willebrand factorbusiness.industrymedicine.diseasecardiovascular diseasesTransplantationPeptide HydrolasechemistryImmunologybusinessFollow-Up StudiesPeptide HydrolasesKidney International
researchProduct

Fenestrated Stent Grafting for Short-necked and Juxtarenal Abdominal Aortic Aneurysm

2010

Objectives: To present an 8-year clinical experience in the endovascular treatment of short-necked and juxtarenal abdominal aortic aneurysm (AAA) with fenestrated stent grafts. Methods: At our tertiary referral centre, all patients treated with fenestrated and branched stent grafts have been enrolled in an investigational device protocol database. Patients with short-necked or juxtarenal AAA managed with fenestrated endovascular aneurysm repair (F-EVAR) between November 2001 and April 2009 were retrospectively reviewed. Patients treated at other hospitals under the supervision of the main author were excluded from the study. Patients treated for suprarenal or thoraco-abdominal aneurysms wer…

MaleTime Factorsmedicine.medical_treatmentShort neckFenestrated graftKaplan-Meier EstimateOPEN REPAIREndovascular aneurysm repairSettore MED/22 - Chirurgia VascolareAortic aneurysmEVARNetherlandsAged 80 and overMedicine(all)medicine.diagnostic_testENDOGRAFT REPAIRMiddle AgedJuxtarenalAbdominal aortic aneurysmProsthesis FailureTreatment OutcomeFemaleKidney DiseasesStentsCardiology and Cardiovascular MedicineReoperationmedicine.medical_specialtyAortographyArterial Occlusive DiseasesFenestrated graftsProsthesis DesignAortographyRisk AssessmentBlood Vessel Prosthesis ImplantationAneurysmRenal DialysisBlood vessel prosthesismedicineHumanscardiovascular diseasesAgedRetrospective Studiesbusiness.industryStentENDOVASCULAR REPAIRmedicine.diseaseAneurysmBlood Vessel ProsthesisSurgeryAbdominal aortic aneurysmSurgerybusinessTomography Spiral ComputedAortic Aneurysm AbdominalAbdominal surgeryEuropean Journal of Vascular and Endovascular Surgery
researchProduct

Complement Activation in Peritoneal Dialysis–Induced Arteriolopathy

2017

Cardiovascular disease (CVD) is the leading cause of increased mortality in patients with CKD and is further aggravated by peritoneal dialysis (PD). Children are devoid of preexisting CVD and provide unique insight into specific uremia- and PD-induced pathomechanisms of CVD. We obtained peritoneal specimens from children with stage 5 CKD at time of PD catheter insertion (CKD5 group), children with established PD (PD group), and age-matched nonuremic controls (n=6/group). We microdissected omental arterioles from tissue layers not directly exposed to PD fluid and used adjacent sections of four arterioles per patient for transcriptomic and proteomic analyses. Findings were validated in omenta…

MaleVascular Endothelial Growth Factor A0301 basic medicinePathologyProteomemedicine.medical_treatmentComplement Membrane Attack ComplexSmad2 ProteinSeverity of Illness IndexTransforming Growth Factor betaMedicinePhosphorylationChildComplement ActivationCatheter insertionGeneral MedicineArteriosclerosisArteriolesComplement C3dNephrologyChild PreschoolFemaleOmentumPeritoneal DialysisSignal Transductionmedicine.medical_specialtyAdolescentPeritoneal dialysis03 medical and health sciencesDownregulation and upregulationClinical ResearchTGF beta signaling pathwayHumansSmad3 ProteinVascular DiseasesUremiabusiness.industryVascular diseaseComplement C1qInfant NewbornInfantComplement System Proteinsmedicine.diseaseUremiaComplement systemGene Ontology030104 developmental biologyCase-Control StudiesKidney Failure ChronicTranscriptomebusinessJournal of the American Society of Nephrology
researchProduct